As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will be early detection. But before addressing the issue of testing, there’s a knotty ribbon problem to be solved.
Related Posts
An army of 12,000 medical reps: How Rajeev Juneja flexed Mankind to the pharma top order
Rajeev Juneja, vice-chairman and managing director, Mankind Pharma; image credit: Company Synopsis While Ramesh Juneja has led Mankind Pharma for…
PE firms in pink of health on improving returns from hospital investments.
Private equity investors have been investing large sums of money in hospitals. Certain types of hospital chains are delivering healthy…
apollo: Apollo Hospitals: all bulked up for its next phase of expansion,yet conservative on acquisitions
Apollo Hospital in Mumbai, India. Synopsis Strong financial and operational performance marked the last five years, a consolidation phase for…
